Patents by Inventor Tesfaledet Mussie

Tesfaledet Mussie has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 16 Alpha, 17 Alpha-Acetal Glucocorticosteroidal Derivatives and their Use
    Publication number: 20110294766
    Abstract: The present invention provides compounds of formula (I) wherein R1, R2, R3, R4, R5 and R6 are as defined in the specification, a process for their preparation, pharmaceutical compositions containing them and their use in therapy.
    Type: Application
    Filed: February 27, 2009
    Publication date: December 1, 2011
    Applicant: AstraZeneca AB
    Inventors: Frank Burkamp, Tesfaledet Mussie, Paul Andersson, Inga-Britt Andersson, Sumita Bhatacharyya, Håkan Bladh, Svetlana Ivanova, Matti Lepistö
  • Steroid Derivatives Acting As Glucocorticosteroid Receptor Agonists
    Publication number: 20110160167
    Abstract: The present invention provides compounds of formula (I) wherein n, p, R1, R2, X1, X2, X3, R3a, R3b, R4, R5 and R6 are as defined in the specification, a process for their preparation, pharmaceutical compositions containing them and their use in therapy.
    Type: Application
    Filed: December 18, 2008
    Publication date: June 30, 2011
    Applicant: AstraZeneca AB
    Inventors: Håkan Bladh, Karl Edman, Thomas Hansson, Karolina Lawitz, Matti Lepistö, Tesfaledet Mussie
  • Novel 1-Benzyl-4-Piperidinamines that are Useful in the Treatment of COPD and Asthma
    Publication number: 20100081692
    Abstract: The invention provides 1-benzyl-4-piperidinamines of the general formula (I), processes for their preparation, pharmaceutical compositions containing them and their use in therapy. The compounds are useful in the treatment of respiratory diseases such as chronic obstructive pulmonary disease and asthma. The compounds are inhibitors of the CCR1 receptor.
    Type: Application
    Filed: October 31, 2006
    Publication date: April 1, 2010
    Applicant: ASTRAZENECA AB
    Inventors: Martin Hemmerling, Nafizal Hossain, Svetlana Ivanova, Tesfaledet Mussie, Igor Shamovsky, Asa Sjoholm Timen
  • Novel Compounds
    Publication number: 20090306141
    Abstract: The invention provides compounds of general formula (I) wherein m, n, Q, Z1, Z2, R1, R2, R3, R4, R5, R6, R7 and R8 are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in therapy.
    Type: Application
    Filed: May 4, 2009
    Publication date: December 10, 2009
    Inventors: Tomas Eriksson, Tomas Klingstedt, Tesfaledet Mussie
  • Compounds
    Patent number: 7528156
    Abstract: The invention provides compounds of general formula (D wherein m, n, Q, Z1, Z2, R1, R2, R3, R4, R5, R6, R7, and R8 are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in therapy.
    Type: Grant
    Filed: November 22, 2004
    Date of Patent: May 5, 2009
    Assignee: AstraZeneca AB
    Inventors: Tomas Eriksson, Tomas Klingstedt, Tesfaledet Mussie
  • Novel Quinoline-Carbaxamides as Jak3 Kinase Modulators
    Publication number: 20080153799
    Abstract: The present invention relates to novel compounds which are JAK3 Kinase inhibitors, methods for their preparation and pharmaceutical compositions comprising them.
    Type: Application
    Filed: February 7, 2005
    Publication date: June 26, 2008
    Applicant: ASTRAZENECA AB
    Inventors: David Laurent, Jorgen Gustafsson, Karolina Lawitz, Tesfaledet Mussie, Antonios Nikitidis
  • Compounds
    Patent number: 6911458
    Abstract: The invention provides compounds of general formula (I) wherein m, n, Q, Z1, Z2, R1, R2, R3, R4, R5, R6, R7 and R8 are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in therapy.
    Type: Grant
    Filed: June 14, 2001
    Date of Patent: June 28, 2005
    Assignee: Astra Zeneca
    Inventors: Tomas Eriksson, Tomas Klingstedt, Tesfaledet Mussie
  • Novel compounds
    Publication number: 20050090494
    Abstract: The invention provides compounds of general formula (I) wherein m, n, Q, Z1, Z2, R1, R2, R3, R4, R5, R6, R7 and R8 are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in therapy.
    Type: Application
    Filed: November 22, 2004
    Publication date: April 28, 2005
    Inventors: Tomas Eriksson, Tomas Klingstedt, Tesfaledet Mussie
  • Novel compounds
    Publication number: 20030162772
    Abstract: The invention provides compounds of general formula (I) wherein m, n, Q, Z1, Z2, R1, R2, R3, R4, R5, R6, R7 and R8 are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in therapy.
    Type: Application
    Filed: February 19, 2003
    Publication date: August 28, 2003
    Inventors: Tomas Eriksson, Tomas Klingstedt, Tesfaledet Mussie